Papers/PMID:40651709
The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial.
The Journal of nutritional biochemistry2025The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid — increases tumour necrosis factor alpha concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“DHA supplementation resulted in greater increases in the plasma cytokines IFN-γ and TNF-α compared to placebo (P-interaction < .05).”
Quoted verbatim from The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial.. - Study
- RCT
- Duration
- 4 months
- Dose
- DHA-enriched algae, 4.4 g/day, 18 weeks
- Population
- women with breast cancer receiving neoadjuvant chemotherapy (both arms)